Aardvark Therapeutics, Inc. Common Stock
HealthcareNASDAQ:AARD · NASDAQ Global Select
+$0.26 today
Vol 0.13M · Avg 0.20M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-63.69%
Period High
$17.41
Period Low
$3.48
Latest
$3.90
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$364.90M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$284.66M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$276.28M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$245.42M
Zura Bio Limited
NASDAQ:ZURA
$240.58M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$202.22M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$166.70M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.19M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$118.59M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$111.51M
What is the latest AARD filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does AARD have?
Intrinsic Alpha currently shows 20 recent filings for AARD.
Explore More
Continue the stock analysis
Jump to another research area for this company.